Delve Bio

Delve Bio is a genomic diagnostics company commercializing clinical metagenomic next-generation sequencing (mNGS) for infectious disease diagnosis. Its flagship test, Delve Detect, analyzes all nucleic acids in a single cerebrospinal fluid sample to simultaneously detect bacteria, viruses, fungi, and parasites, screening against a curated database of more than 68,000 pathogen species to diagnose meningitis and encephalitis with results in roughly 48 hours. The company is the exclusive licensee of the University of California San Francisco (UCSF) mNGS technology developed at the Center for Next-Gen Precision Diagnostics, founded by Charles Chiu, Joe DeRisi, Michael Wilson, Pardis Sabeti, and Matthew Meyerson, and backed by investors including GV. Delve Bio operates as a CAP/CLIA-certified clinical laboratory serving labs and clinicians; it exposes no public developer API surface. Added to the API Evangelist network as a gv portfolio lead.

Delve Bio is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Diagnostics, Metagenomics, and Infectious Disease.

Delve Bio’s developer surface includes getting-started guide, support, engineering blog, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.5/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyLife SciencesDiagnosticsMetagenomicsInfectious DiseaseGenomicsNext-Generation SequencingPrecision MedicineClinical Laboratory

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.5/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 3.5 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/delve-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Get Started 1

Portal, sign-up, and the first successful call

GettingStarted

GettingStarted

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: delve-bio
name: Delve Bio
description: Delve Bio is a genomic diagnostics company commercializing clinical metagenomic next-generation sequencing (mNGS)
  for infectious disease diagnosis. Its flagship test, Delve Detect, analyzes all nucleic acids in a single cerebrospinal
  fluid sample to simultaneously detect bacteria, viruses, fungi, and parasites, screening against a curated database of more
  than 68,000 pathogen species to diagnose meningitis and encephalitis with results in roughly 48 hours. The company is the
  exclusive licensee of the University of California San Francisco (UCSF) mNGS technology developed at the Center for Next-Gen
  Precision Diagnostics, founded by Charles Chiu, Joe DeRisi, Michael Wilson, Pardis Sabeti, and Matthew Meyerson, and backed
  by investors including GV. Delve Bio operates as a CAP/CLIA-certified clinical laboratory serving labs and clinicians; it
  exposes no public developer API surface. Added to the API Evangelist network as a gv portfolio lead.
url: https://raw.githubusercontent.com/api-evangelist/delve-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
image: https://www.delve.bio/wp-content/uploads/2025/05/Delve.webp
tags:
- Company
- Life Sciences
- Diagnostics
- Metagenomics
- Infectious Disease
- Genomics
- Next-Generation Sequencing
- Precision Medicine
- Clinical Laboratory
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.delve.bio
- type: GettingStarted
  url: https://www.delve.bio/start/
- type: Support
  url: https://www.delve.bio/company/contact/
- type: Blog
  url: https://www.delve.bio/news/
- type: GitHubOrganization
  url: https://github.com/delvebio
- type: PrivacyPolicy
  url: https://www.delve.bio/privacy/
- type: TermsOfService
  url: https://www.delve.bio/terms/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence